Gui Zhao

Department Of R&D
Shanghai, 201203, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Pulsed Electrolysis Promotes CO2 Electroreduction to Multicarbon Products by Suppressing Electrolyte Flooding.

Pulsed Electrolysis Promotes CO2 Electroreduction to Multicarbon Products by Suppressing Electrolyte Flooding.

Journal: Angewandte Chemie (International ed. in English)

Published: October 04, 2025

Atomically dispersed Ru in ZIF-67 as a high-performance HER catalyst: in situ structural evolution and deactivation mechanism elucidation.

Atomically dispersed Ru in ZIF-67 as a high-performance HER catalyst: in situ structural evolution and deactivation mechanism elucidation.

Journal: Materials horizons

Published: September 04, 2025

Electrifying HCOOH synthesis from CO2 building blocks over Cu-Bi nanorod arrays.

Electrifying HCOOH synthesis from CO2 building blocks over Cu-Bi nanorod arrays.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: July 09, 2024

IMM2520, a novel anti-CD47/PD-L1 bispecific antibody for cancer immune therapy.

IMM2520, a novel anti-CD47/PD-L1 bispecific antibody for cancer immune therapy.

Journal: Heliyon

Published: April 10, 2024

Combining CD38 antibody with CD47 blockade is a promising strategy for treating hematologic malignancies expressing CD38.

Combining CD38 antibody with CD47 blockade is a promising strategy for treating hematologic malignancies expressing CD38.

Journal: Frontiers in immunology

Published: March 10, 2024

Unraveling distinct effects between CuOx and PtCu alloy sites in Pt-Cu bimetallic catalysts for CO oxidation at different temperatures.

Unraveling distinct effects between CuOx and PtCu alloy sites in Pt-Cu bimetallic catalysts for CO oxidation at different temperatures.

Journal: Nature communications

Published: September 27, 2023

The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling.

The novel high-affinity humanized antibody IMM40H targets CD70, eliminates tumors via Fc-mediated effector functions, and interrupts CD70/CD27 signaling.

Journal: Frontiers in oncology

Published: June 14, 2023

IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy.

IMM47, a humanized monoclonal antibody that targets CD24, exhibits exceptional anti-tumor efficacy by blocking the CD24/Siglec-10 interaction and can be used as monotherapy or in combination with anti-PD1 antibodies for cancer immunotherapy.

Journal: Antibody therapeutics

Published: June 01, 2023

IMM0306, a fusion protein of CD20 mAb with the CD47 binding domain of SIRPα, exerts excellent cancer killing efficacy by activating both macrophages and NK cells via blockade of CD47-SIRPα interaction and FcɣR engagement by simultaneously binding to CD47 and CD20 of B cells.

IMM0306, a fusion protein of CD20 mAb with the CD47 binding domain of SIRPα, exerts excellent cancer killing efficacy by activating both macrophages and NK cells via blockade of CD47-SIRPα interaction and FcɣR engagement by simultaneously binding to CD47 and CD20 of B cells.

Journal: Leukemia

Published: October 30, 2022

SIRPα-Fc fusion protein IMM01 exhibits dual anti-tumor activities by targeting CD47/SIRPα signal pathway via blocking the "don't eat me" signal and activating the "eat me" signal.

SIRPα-Fc fusion protein IMM01 exhibits dual anti-tumor activities by targeting CD47/SIRPα signal pathway via blocking the "don't eat me" signal and activating the "eat me" signal.

Journal: Journal of hematology & oncology

Published: September 11, 2022

Crystal Structure of Human CD47 in Complex with Engineered SIRPα.D1(N80A).

Crystal Structure of Human CD47 in Complex with Engineered SIRPα.D1(N80A).

Journal: Molecules (Basel, Switzerland)

Published: July 15, 2022

A PtPdCoCuNi high-entropy alloy nanocatalyst for the hydrogenation of nitrobenzene.

A PtPdCoCuNi high-entropy alloy nanocatalyst for the hydrogenation of nitrobenzene.

Journal: RSC advances

Published: May 19, 2022

Showing 1-12 of 12

Last Updated: 09/26/2026